GNTA Genenta Science S.p.A. - American Depositary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Apr 1, 2026
$0.75
· of 52w range
· above low
· to high
$0.5552w low
$10.0052w high
Market Cap
$17M
P/E
-2.3
EPS
$-0.33
your badges
52W Range
$1–$10
Analyst Rating
BUY
Price Target
$7
P/E
-2.3
ROE
-38.0%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
GNTA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.74
Market Cap
$17M
P/E
-2.3
EPS
$-0.33
ROE
-38.0%
52W Range
$1–$10
GNTA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.332021-12-31 → 2025-12-31
Free Cash Flow$-7M2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | GNTA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -2.35Y avg ≈-12.5 | ≈-12.5 | · | · | |
| P/B | 0.85Y avg ≈4.1 | ≈4.1 | · | · | |
| Price / FCF | -2.55Y avg ≈-13.6 | ≈-13.6 | · | · | |
| Price / Cash Flow | -2.55Y avg ≈-13.6 | ≈-13.6 | · | · | |
| Price / Tangible Book | 0.85Y avg ≈4.1 | ≈4.1 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | GNTA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -28.0%5Y avg ≈-32.0% | ≈-32.0% | · | · | |
| ROE | -38.0%5Y avg ≈-36.4% | ≈-36.4% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | GNTA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 14.25Y avg ≈16.4 | ≈16.4 | · | · | |
| Quick Ratio | 13.35Y avg ≈15.3 | ≈15.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $5M | $6M | $5M | $3M | $5M | |
| SG&A Expense | $4M | $5M | $5M | $6M | $2M | $901.8K | |
| Operating Expenses | $7M | $10M | $12M | $11M | $6M | $6M | |
| Operating Income | $-7M | $-10M | $-12M | $-11M | $-6M | $-6M | |
| Other Non-op | $11.5K | $529.7K | $-4.9K | $242.6K | $19.7K | $6.0K | |
| Pretax Income | $-7M | $-9M | $-12M | $-8M | $-6M | $-6M | |
| Net Income | $-7M | $-9M | $-12M | $-8M | $-6M | $-6M | |
| EPS (Basic) | · | · | $-0.64 | $-0.47 | $-0.37 | · | |
| EPS (Diluted) | $-0.33 | $-0.49 | $-0.64 | $-0.47 | $-0.37 | · | |
| Shares (Basic) | 19,710,187 | 18,273,490 | 18,216,907 | 18,216,858 | 15,083,825 | · | |
| Shares (Diluted) | 19,710,187 | 18,273,490 | 18,216,907 | 18,216,858 | 15,083,825 | · | |
| EBITDA | $-7M | $-10M | $-12M | $-11M | $-6M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $5M | $4M | $30M | $37M | $15M | |
| Short-term Investments | $23M | $8M | $15M | · | · | · | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $2M | $947.5K | |
| Other Current Assets | · | $210.8K | $64.7K | $219.4K | $22.0K | · | |
| Current Assets | $30M | $14M | $21M | $32M | $39M | $17M | |
| PP&E (Net) | $22.5K | $42.9K | $83.0K | $111.6K | $23.1K | $19.0K | |
| PP&E (Gross) | $148.9K | $141.2K | $136.8K | $123.8K | $29.9K | $20.9K | |
| Accum. Depreciation | $126.4K | $98.3K | $53.8K | $12.1K | $6.8K | $1.9K | |
| Intangibles | · | · | · | $87.0K | · | · | |
| Other Non-current Assets | · | · | · | $2M | $1M | $945.6K | |
| Total Assets | $32M | $15M | $22M | $33M | $40M | $18M | |
| Accounts Payable | · | · | · | $1M | $164.8K | $545.0K | |
| Accrued Liabilities | · | · | · | $202.4K | $712.3K | $366.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $1M | $2M | |
| Other Non-current Liabilities | · | $1.2K | $14.6K | $27.2K | · | · | |
| Common Stock | $84M | $68M | $67M | $67M | $66M | · | |
| Paid-in Capital | · | · | · | · | · | $37M | |
| Retained Earnings | $-63M | $-56M | $-47M | $-35M | $-27M | $-21M | |
| AOCI | $166.5K | $88.9K | $231.1K | · | · | · | |
| Stockholders' Equity | $22M | $12M | $20M | $31M | $39M | $15M | |
| Liabilities + Equity | $32M | $15M | $22M | $33M | $40M | $18M | |
| Shares Outstanding | 23,432,183 | 18,289,866 | 18,216,958 | 18,216,858 | 18,216,858 | 18,216,858 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $28.1K | $44.5K | $42.5K | $6.1K | $4.9K | $1.9K | |
| Stock-based Comp | $1M | $847.3K | $739.9K | $722.7K | $497.1K | $460.2K | |
| Other Non-cash | $-1M | $2M | $-341.9K | $330.7K | $-2M | · | |
| Operating Cash Flow | $-7M | $-6M | $-11M | $-7M | $-7M | $-6M | |
| CapEx | $7.6K | $4.5K | $13.8K | $27.1K | $9.0K | $20.9K | |
| Investing Cash Flow | $-15M | $7M | $-15M | $-27.1K | $-9.0K | $-20.9K | |
| Stock Issued | · | · | · | · | · | $2M | |
| Financing Cash Flow | $22M | $270.9K | $531 | · | $29M | $1M | |
| Net Change in Cash | · | · | · | $-7M | $22M | $-5M | |
| Free Cash Flow | $-7M | $-6M | $-11M | $-7M | $-7M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -28.0% | -47.9% | -41.8% | -23.1% | -19.2% | · | |
| ROE | -38.0% | -54.1% | -45.2% | -24.2% | -20.5% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 14.2 | 6.9 | 12.2 | 14.5 | 34.1 | · | |
| Quick Ratio | 13.3 | 6.0 | 10.8 | 13.6 | 32.8 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.93 | $0.68 | $1.12 | $1.71 | $2.13 | · | |
| Cash Flow / Share | $-0.35 | $-0.34 | $-0.62 | · | · | · | |
| Cash / Share | $0.24 | $0.25 | $0.20 | $1.64 | $2.04 | · | |
| EPS (TTM) | $-0.33 | $-0.49 | $-0.64 | $-0.47 | $-0.37 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-7M | $-9M | $-12M | $-8M | $-6M | · | |
| Market Cap | $35M | $80M | $90M | $100M | $200M | · | |
| P/E | -4.5 | -8.9 | -7.7 | -11.7 | -29.6 | · | |
| P/B | 1.6 | 6.4 | 4.4 | 3.2 | 5.1 | · | |
| P / Tangible Book | 1.6 | 6.4 | 4.4 | 3.2 | 5.1 | · | |
| P / Cash Flow | -5.1 | -12.7 | -8.0 | -13.5 | -28.7 | · | |
| P / FCF | -5.1 | -12.7 | -8.0 | -13.5 | -28.7 | · | |
| Earnings Yield | -22.1% | -11.3% | -12.9% | -8.6% | -3.4% | · |
Per Share
| Metric | Trend | Q4 2023 |
|---|---|---|
| EPS (TTM) | $-0.64 |
Valuation (TTM)
| Metric | Trend | Q4 2023 |
|---|---|---|
| Net Income TTM | $-12M | |
| P/E | -7.7 | |
| Earnings Yield | -12.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-7M | $-9M | $-12M | $-8M | $-6M |
| Diluted EPS | $-0.33 | $-0.49 | $-0.64 | $-0.47 | $-0.37 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 14.2 | 6.9 | 12.2 | 14.5 | 34.1 |
| Quick Ratio | 13.3 | 6.0 | 10.8 | 13.6 | 32.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-7M | $-6M | $-11M | $-7M | $-7M |
Institutional owners (13F) 9 filers · $1.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
9
Value held
$1.3M
New positions
2
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (-1 vs prior Q) | 4 (-2 vs prior Q) | 1 (-1 vs prior Q) | 3 (+1 vs prior Q) | -315K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Eurizon Capital SGR S.p.A. | $662,400 | 360,000 | 52.65% | Shares |
| Allianz SE | $430,652 | 234,050 | 34.23% | Shares |
| SmartHarvest Portfolios, LLC | $80,695 | 43,856 | 6.41% | Shares |
| Simplicity Wealth,LLC | $34,206 | 18,590 | 2.72% | Shares |
| Ground Swell Capital, LLC | $26,448 | 14,374 | 2.10% | Shares |
| GAMMA Investing LLC | $18,148 | 9,863 | 1.44% | Shares |
| UBS Group AG | $5,570 | 3,027 | 0.44% | Shares |
| Virtu Financial LLC | $68 | 36,913 | 0.01% | Shares |
| Farther Finance Advisors, LLC | $6 | 3 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| BF & F S.r.l., Bernhard Gentner, Ferragamo Finanziaria S.p.A., Fidim S.p.A., Fin Posillipo S.p.A., Gaudenzio Roveda, Globe 2017 S.r.l., Luigi Naldini, Marco Nuzzo, Vittorio Avogadro di Collobiano, Vyoda S.r.l. | Oct. 2, 2026 | 11.50% | Amendment | Passive investment | SEC |
| Marco Nuzzo, Luigi Naldini, Bernhard Gentner, Globe 2017 S.r.l., Ferragamo Finanziaria S.p.A., Gaudenzio Roveda, Fidim S.p.A., Fin Posillipo S.p.A., BF & F S.r.l., Vyoda S.r.l., Vittorio Avogadro di Collobiano | May 5, 2026 | 23.00% | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 6 insiders · 3 officers · 5 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Paracchi Pierluigi | Chief Executive Officer | March 30, 2026 A | · | 0 | 0 | $0 |
| Richard B Slansky | Chief Financial Officer | March 30, 2026 A | · | 0 | 0 | $0 |
| Francesco Galimi | CMO& Head of Development | March 30, 2026 A | · | 0 | 0 | $0 |
| Giacomoantonio Paracchi | Director | March 30, 2026 A | · | 0 | 0 | $0 |
| Miguel Maria Mutti | Director | March 30, 2026 A | · | 0 | 0 | $0 |
| Armon Sharei | Director | March 30, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
GNTA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$6.99
+837.7%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-05-01Mean target $6.99 +837.7%
Low$6.99
Mean$6.99
High$6.99
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Apr 1, 2026